No news is not always good news, but the medtech sector has become accustomed to the UK government's lack of guidance on the continuity of regulation and trade after the UK leaves the EU next March. And what of the proposed transition period to December 2020? The value of that to the medtech industry – in and beyond the UK – is still not clear.
The latest EU summit, on June 27-28, includes an EU27 roundtable to review the state of play and progress of...
Welcome to Medtech Insight
Create an account to read this article
Already a subscriber?